Trends, Characteristics, and Clinical Outcomes of Patients Undergoing Percutaneous Coronary Intervention in Korea between 2011 and 2015

다국어 초록 (Multilingual Abstract)

Background and Objectives: We sought to evaluate nationwide trends, characteristics, and clinical outcomes in patients undergoing percutaneous coronary intervention (PCI) in Korea.
Methods: From National Health Insurance claims data in Korea, 81,115 patients, who underwent PCI for the first episode of coronary artery disease between 2011 and 2015, were enrolled. Patients were categorized into angina (n=49,288) or acute myocardial infarction (AMI, n=31,887) groups and analyzed.
Results: The mean age of patients was 64.4±12.2 years and 56,576 (69.7%) were men. Diabetes, hyperlipidemia, and hypertension were observed in 27,086 (33.4%), 30,675 (37.8%), and 45,389 (56.0%) patients, respectively. There was a 10% increase in the number of patients undergoing PCI for angina between 2011–2012 and 2014–2015 (11,105 vs. 13,261; p=0.021). However, the number of patients undergoing PCI for AMI marginally decreased between 2011–2012 and 2014–2015 (8,068 vs. 7,823; p=0.052). In procedures, drug-eluting stent was the most frequently used device (93.2%), followed by balloon angioplasty (5.5%) and bare metal stents (1.3%). The mean number of stents per patient was 1.39±0.64. At discharge, dual-anti platelet therapy, statin, beta-blockers, and angiotensin converting enzyme inhibitor or angiotensin receptor blocker were provided to 76,292 (94.1%), 71,411 (88.0%), 57,429 (70.8%), and 54,418 (67.1%) patients, respectively. The mean in-hospital and 1-year total medical costs were 8,628,768±4,832,075 and 13,128,158±9,758,753 Korean Won, respectively. In-hospital mortality occurred in 2,094 patients (2.6%).
Conclusions: Appropriate healthcare strategies reflecting trends, characteristics, and clinical outcomes of PCI are needed in Korea.

참고문헌 (Reference)

1 권현철, "The Practice Pattern of Percutaneous Coronary Intervention in Korea –Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry–" 대한심장학회 47 (47): 320-327, 2017

2 장재식, "The Current Status of Percutaneous Coronary Intervention in Korea –Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry–" 대한심장학회 47 (47): 328-340, 2017

3 Harnek J, "The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART)" 47 (47): 1-10, 2013

4 Palmerini T, "Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis" 379 : 1393-1402, 2012

5 Camenzind E, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern" 115 : 1440-1455, 2007

6 Wilson PW, "Prediction of coronary heart disease using risk factor categories" 97 : 1837-1847, 1998

7 Bangalore S, "Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials" 6 : 378-390, 2013

8 Goyal A, "Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery" 83 : 993-1001, 2007

9 Boden WE, "Optimal medical therapy with or without PCI for stable coronary disease" 356 : 1503-1516, 2007

10 Iqbal J, "Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up" 131 : 1269-1277, 2015

11 Park GM, "Model for assessing cardiovascular risk in a Korean population" 7 : 944-951, 2014

12 Lagerqvist B, "Long-term outcomes with drug-eluting stents versus baremetal stents in Sweden" 356 : 1009-1019, 2007

13 Lin GA, "Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention" 300 : 1765-1773, 2008

14 Conroy RM, "Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project" 24 : 987-1003, 2003

15 Lee PH, "Effect of beta blockers and renin-angiotensin system inhibitors on survival in patients with acute myocardial infarction undergoing percutaneous coronary intervention" 95 : e2971-, 2016

16 McWilliams JM, "Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage" 150 : 505-515, 2009

17 Kook HY, "Current trend of acute myocardial infarction in Korea (from the Korea Acute Myocardial Infarction Registry from 2006 to 2013)" 114 : 1817-1822, 2014

18 Epstein AJ, "Coronary revascularization trends in the United States, 2001-2008" 305 : 1769-1776, 2011

19 Quan H, "Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data" 43 : 1130-1139, 2005

20 Park GM, "Clinical impact and cost-effectiveness of coronary computed tomography angiography or exercise electrocardiogram in individuals without known cardiovascular disease" 94 : e917-, 2015

21 Ueshima H, "Cardiovascular disease and risk factors in Asia: a selected review" 118 : 2702-2709, 2008

22 Shreibati JB, "Association of coronary CT angiography or stress testing with subsequent utilization and spending among Medicare beneficiaries" 306 : 2128-2136, 2011

23 Park GM, "Anatomic or functional evaluation as an initial test for stable coronary artery disease: a propensity score analysis" 57 : 1364-1369, 2016

24 Nabel EG, "A tale of coronary artery disease and myocardial infarction" 366 : 54-63, 2012

25 Levine GN, "2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines" 68 : 1082-1115, 2016

26 Authors/Task Force membersWindecker S, "2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)" 35 : 2541-2619, 2014